Qcor has been in the news a lot recently and may end up drawing attention to itself. qcor is doing lots of clinical trials,synathen purchase, biovectra purchase, applying for orphan drug status for ALS, no debt, multiple fda approve labels, no poison pill, hiring well connected board member(Angus),more analysts covering (GS soon?), etc etc. And Big Pharma, in many cases is hurting to add to their pipelines. Stay tuned!